Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis

Overview of attention for article published in Frontiers in endocrinology, August 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 13 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 18,667 followers.

Frontiers | Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis A recent publication ⁦@doc_hormone⁩ https://t.co/x0Q8aDL6QE

09 Sep 2024

Reply Repost Favourite

Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis https://t.co/uFVTT6h47a

15 Aug 2023

Reply Repost Favourite

RT @FrontEndocrinol: New Research: Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis…

10 Aug 2023

Reply Repost Favourite

New Research: Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis: Aims Due to its high heterogenicity and unclear etiology, there is currently no specific treatment for… #Endocrinology #Endo https://t.

10 Aug 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.